Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combination of Pre-screening for DPD Deficiency by Genotyping/phenotyping Methods and Pharmacokinetics-guided Dosing of 5-FU for Precision Treatment to Prevent Severe Toxicity in Gastrointestinal Cancer Patients.

NCT06782022 is registered in ClinicalTrials.gov with Jan Gerard Maring as lead sponsor.

NCT NCT06782022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combination of Pre-screening for DPD Deficiency by Genotyping/phenotyping Methods and Pharmacokinetics-guided Dosing of 5-FU for Precision Treatment to Prevent Severe Toxicity in Gastrointestinal Cancer Patients.
Lead sponsor
Jan Gerard Maring
Phase
Phase 2
Overall status
Completed
Start date
February 2, 2020
Completion date
October 31, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancers